April 20, 2024
Battery Ventures acquires Labguru from Holtzbrinck Digital

Kindeva Drug Delivery Appoints Jennifer Riter as New VP of Analytical Services

Jennifer-Riter-joins-Kindeva-Drug-Delivery-as-Vice-President-of-Analytical-Services-to-lead-new-analytical-services-business-unit.-Photo-Business-Wire
Jennifer-Riter-joins-Kindeva-Drug-Delivery-as-Vice-President-of-Analytical-Services-to-lead-new-analytical-services-business-unit.-Photo-Business-Wire

Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, recently welcomed Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit.

Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations. She brings specific leadership and expertise in analytical testing which includes extractables and leachables, container closure integrity and device/combination product performance, and particle analysis. She is the current Chair of the Board of Directors for the Lock Haven University Foundation and teaches a class at University of Maryland Baltimore County as part of the combination products curriculum.

“Kindeva’s expertise in all areas of drug delivery and manufacturing is unmatched in the industry,” Riter said. “I am looking forward to working with the team on expanding our capabilities and expertise in analytical services and working with customers on their analytical approach and strategy for their combination products.”

“Jennifer’s experience blends knowledge of primary packaging components and containment and delivery systems with hands-on experience of providing technical support and analytical solutions to multinational customers,” said Kindeva Global Chief Commercial Officer David Stevens. “The long list of experience and technical knowledge she brings to the team enhances Kindeva as a global drug-device combination CDMO as well as builds the future of integrated and stand-alone analytical support for the wider pharmaceutical, biopharmaceutical, and medical device sector.”

Source

(Visited 20 times, 1 visits today)

Share:

Facebook
Twitter
WhatsApp
LinkedIn

Comments are closed.

Social Media

Most Popular

LRMF missile
Aerojet Rocketdyne joins Lockheed Martin to develop LRMF missile
Maria Jackson
BOURNEWOOD HEALTH SYSTEMS onboards Maria Jackson as CEO
Tahini located in the vibrant One Central.
GRIT Hospitality launches Tahini in Dubai
3D-Systems-EXT-1070-Titan-Pellet-printer
3D Systems and SWANY partnership to promote large-format pellet extrusion 3D printing

Related Posts